ARCH leads $130M infusion into Be Bio’s long pursuit of B cell therapies for rare disease, cancer April 14, 2022
Neuro player Jazz Pharmaceuticals Dives into Immuno-Oncology, Inking Cytokine Pact with Werewolf April 8, 2022
Safety and target engagement of an oral small-molecule sequestrant in adolescents with autism spectrum disorder: an open-label phase 1b/2a trial February 14, 2022
